MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 576116 | Name: GYKI-12743 HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

GYKI-12743 HCl is a postsynaptic vascular alpha-adrenoceptor antagonist.

Chemical Structure

GYKI-12743 HCl
GYKI-12743 HCl
CAS#110714-10-8

Theoretical Analysis

MedKoo Cat#: 576116

Name: GYKI-12743 HCl

CAS#: 110714-10-8

Chemical Formula: C16H20ClN3O3

Exact Mass: 337.1193

Molecular Weight: 337.80

Elemental Analysis: C, 56.89; H, 5.97; Cl, 10.49; N, 12.44; O, 14.21

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
GYKI12743; GYKI 12743; GYKI-12743 HCl; GYKI-12743 hydrochloride
IUPAC/Chemical Name
3(2H)-Pyridazinone, 2-(3-(((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)amino)propyl)-, monohydrochloride
InChi Key
WJDFSAOMSJHHCG-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H19N3O3.ClH/c20-16-7-3-9-18-19(16)10-4-8-17-11-13-12-21-14-5-1-2-6-15(14)22-13;/h1-3,5-7,9,13,17H,4,8,10-12H2;1H
SMILES Code
Cl.O=C1C=CC=NN1CCCNCC2COc3ccccc3O2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Solvent mg/mL mM
Solubility
Soluble in DMSO 0.0 100.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 337.80 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Rabloczky G, Jaszlits L, Horváth E. GYKI-12743 a new postsynaptic vascular alpha-adrenoceptor antagonist. Acta Physiol Hung. 1991;77(3-4):257-67. PMID: 1684485. 2. Bakonyi A, Horváth EJ. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies. Acta Physiol Hung. 1994;82(4):295-300. PMID: 7785439.